Projects per year
Personal profile
Education
- 2004 PhD, Institute of Clinical Medicine, National Cheng Kung University
Experience
- 1998.08~Present Surgeon/Department of Surgery, NCKUH
- 2002.08~2008.07 Assistant professor/Department of Surgery, NCKU
- 2008.08~ 2012.07 Associate professor/Department of Surgery, NCKU
- 2010.08~2012.07 Associate professor/Institute of Clinical Medicine, NCKU
- 2010.10~Present Convener of UGI Cancer/NCKUH
- 2012.08~2016.07 Professor/Institute of Clinical Medicine, NCKU
- 2016.08~Present Director/Department of Clinical Medical Research, NCKUH
- 2016.08~Present Distinguished Professor/Institute of Clinical Medicine, NCKU
- 2017.08~Present Director/Institute of Clinical Medicine, NCKU
Research Interests
- Gastrointestinal physiology
- GI Clinical Oncology
- Tumor microenvironment (interaction between cancer cells and stromal cells)
- Liver Fibrosis and Regeneration
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Yan-Shen Shan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 31 Finished
-
-
以多重研究法解開組織缺氧-纖維化循環在胰臟癌之病理機制及發展新穎治療策略-組織缺氧-纖維化循環在胰臟癌生成與進展、免疫抑制及抗藥性之角色：聚焦於癌細胞與癌症相關纖維母細胞交互作用( II )
21-08-01 → 22-07-31
Project: Research project
-
-
以多重研究法解開組織缺氧-纖維化循環在胰臟癌之病理機制及發展新穎治療策略-組織缺氧-纖維化循環在胰臟癌生成與進展、免疫抑制及抗藥性之角色：聚焦於癌細胞與癌症相關纖維母細胞交互作用( I )
20-08-01 → 21-07-31
Project: Research project
-
-
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial
APACT Investigators, 2023 Apr 10, In: Journal of Clinical Oncology. 41, 11, p. 2007-2019 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized Study
Taiwan Cooperative Oncology Group pancreatic cancer study group, 2023, (Accepted/In press) In: International Journal of Radiation Oncology Biology Physics.Research output: Contribution to journal › Article › peer-review
-
Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis
Hu, C. Y., Wu, H. T., Shan, Y. S., Wang, C. T., Shieh, G. S., Wu, C. L. & Ou, H. Y., 2023 Apr, In: International journal of molecular sciences. 24, 7, 6021.Research output: Contribution to journal › Article › peer-review
Open Access -
Feasibility of simultaneous development of laparoscopic and robotic pancreaticoduodenectomy
Chao, Y. J., Lu, W. H., Liao, T. K., Su, P. J., Wang, C. J., Lai, C. H., Hung, J. Y., Su, P. F. & Shan, Y. S., 2023 Dec, In: Scientific reports. 13, 1, 6190.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of trauma teams on high grade liver injury care: a two-decade propensity score approach study in Taiwan
Tang, W. R., Wu, C. H., Yang, T. H., Yen, Y. T., Hung, K. S., Wang, C. J. & Shan, Y. S., 2023 Dec, In: Scientific reports. 13, 1, 5429.Research output: Contribution to journal › Article › peer-review
Open Access